Novel oncolytic vaccinia virus armed with interleukin-27 is a potential therapeutic agent for the treatment of murine pancreatic cancer
Background Pancreatic cancer has a complex immunosuppressive tumor microenvironment (TME), which is highly resistant to conventional therapies and emerging cancer immunotherapies. Oncolytic viruses are multifaceted killers of malignant tumors, which can selectively infect, replicate in and lyse tumo...
Saved in:
| Main Authors: | Bing Han, Yong Yang, Zhe Zhang, Pengju Wang, Yaohe Wang, Louisa S Chard Dunmall, Lihong Wang, Lijuan Chen, Ruimin Wang, Yanru Wang, Yangyang Jia, Guanghao Zhao, Wenyi Yan, Nicholas R Lemoine |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-05-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/13/5/e010341.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
A novel oncolytic Vaccinia virus armed with IL-12 augments antitumor immune responses leading to durable regression in murine models of lung cancer
by: Lijuan Chen, et al.
Published: (2025-01-01) -
Oncolytic Vaccinia Virus Armed with GM-CSF and IL-7 Enhances Antitumor Immunity in Pancreatic Cancer
by: Wenyi Yan, et al.
Published: (2025-04-01) -
GM-CSF and IL-21-armed oncolytic vaccinia virus significantly enhances anti-tumor activity and synergizes with anti-PD1 immunotherapy in pancreatic cancer
by: Yujing Xuan, et al.
Published: (2025-01-01) -
Advances of oncolytic vaccinia viruses armed with interleukin in tumor therapy
by: Mingyong Zha, et al.
Published: (2025-05-01) -
Systemic Delivery of Oncolytic Viruses: Hopes and Hurdles
by: Mark S. Ferguson, et al.
Published: (2012-01-01)